Tag:
Jean-Luc Belingard
Latest Headlines
Latest Headlines
Ipsen execs juggling 'too many' pipeline projects
Ipsen CEO Jean-Luc Belingard is plagued by the abundance of promising drugs in his pipeline. "We have enough products in early development, we may even have too many," he tells Bloomberg in an
R&D costs blunt Ipsen profits
European pharmaceuticals firm Ipsen posted first-half profits of €112.9 million on €463.2 million in sales. Though sales were up year-over-year by 7.6%, profits rose only 4.2 percent, in
